mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals

Longet, S., Hargreaves, A., Healy, S. et al. (12 more authors) (2022) mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals. Frontiers in Immunology, 13. 953949. ISSN 1664-3224

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2022 Longet, Hargreaves, Healy, Brown, Hornsby, Meardon, Tipton, Barnes, Dunachie, Duncan, Klenerman, Richter, Turtle, de Silva and Carroll. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Keywords: antibody responses; mucosal immunity; SARS-CoV-2; mRNA vaccination; neutralizing responses; ACE2 inhibition
Dates:
  • Published: 8 September 2022
  • Published (online): 8 September 2022
  • Accepted: 22 August 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection and Immunity (Sheffield)
Funding Information:
Funder
Grant number
MEDICAL RESEARCH COUNCIL
MR/W02067X/1
Depositing User: Symplectic Sheffield
Date Deposited: 11 Oct 2022 10:47
Last Modified: 11 Oct 2022 10:47
Status: Published
Publisher: Frontiers Media S.A.
Refereed: Yes
Identification Number: 10.3389/fimmu.2022.953949
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics